Fairvalue-Calculator Fairvalue-Calculator
EN DE

Pluri Inc (PSTI) Fair Value & Analysis

Healthcare · Il · Market cap 117M ILA

Price6.00 ILA
Fair Value7.95 ILA
Upside+32.5%
Quality89/100
Evidence: Low Range 5.96 ILA – 9.94 ILA

Fair value as of: Jun 24, 2026

Analysis

Pluri Inc (PSTI) currently trades at 6.00 ILA, while our model-based Fair Value estimate is 7.95 ILA — implying the stock looks roughly 32.5% undervalued today. We read business quality at 89/100 (high quality), in the Healthcare sector. Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: low) — always confirm before acting.

About the company

Pluri Inc., a biotechnology company, focuses on the development of placenta-based cell therapy product candidates for the treatment of multiple inflammatory, muscle injuries, and hematologic conditions. The company develops placental expanded (PLX) based cell therapy products, including PLX-PAD that is in Phase III clinical trials for the muscle recovery after surgery for hip fracture; in Phase II clinical trails for the treatment of acute respiratory distress syndrome associated with COVID-19; and in Phase I/II clinical trial for treatment of steroid-refractory graft versus host disease. It also develops PLX-R18 for incomplete hematopoietic recovery following hematopoietic cell transplantation, as well as a solution for the treatment of acute radiation syndrome. The company was formerly known as Pluristem Therapeutics Inc. and changed its name to Pluri Inc. in July 2022. Pluri Inc. was incorporated in 2001 and is based in Haifa, Israel.

Open the full interactive analysis →

Similar stocks

Peptron, Inc (087010) -81% MEDIPOST Co (078160) +172% Bioneer Corporation (064550) -58% Macrogen, Inc (038290) -63% Cell Biotech Co (049960) +18% Panagene Inc (046210) +15%

Frequently asked questions

Is Pluri Inc (PSTI) undervalued?
As of Jun 24, 2026, our model estimates a fair value of 7.95 ILA versus a price of 6.00 ILA — about +33% (undervalued). Model-based estimate, not financial advice.
What is the fair value of PSTI?
Our 21-model fair value for Pluri Inc is 7.95 ILA (as of Jun 24, 2026), built from audited fundamentals. The current price is 6.00 ILA.
What is the quality score of PSTI?
Pluri Inc has a Quality Score of 89/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.